PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33500737-7	2021	5-FU and miR-34a(m) were loaded into TCP1-CD-QD nanocarriers, which were used to treat CRC in vitro and in vivo.	Fluorouracil	0-4	t-complex 1	Homo sapiens	37-41	
33500737-9	2021	Results: 5-FU and miR-34a(m) can be efficiently encapsulated into TCP1-CD-QD nanocarriers and delivered into CRC cells, which led to the inhibition of the proliferation and migration of CRC cells in vitro and suppression of tumor growth in a CRC cell-derived tumor xenograft model.	Fluorouracil	9-13	t-complex 1	Homo sapiens	66-70	
33500737-11	2021	Notably, targeted therapy via the co-delivery of 5-FU and miR-34a(m) by TCP1-CD-QD nanocarriers significantly inhibited the growth of PDX tumors.	Fluorouracil	49-53	t-complex 1	Homo sapiens	72-76